New Article Shows Different Sides of Business and Clinical Research in India

A new article published in Applied Clinical Trials Magazine addresses and challenges some of the most common myths related to the conduct of business and clinical research in India. The article, titled "Demystifying India -Understanding common myths and truths surrounding one of the fastest growing clinical trial markets" provides readers with a unique perspective on the unique realities of daily life in India which impact clinical research in different ways. Topics/myths covered include a discussion on the the stability of the market, the complexity and timeliness of the regulatory environment, the structure and operating process of IRBs, the informed consent process and the enrollment of patients in India. Below is a small excerpt from the article. Please click on the link to proceed to the Applied Clinical Trials Online website to read the full article:

Excerpt from "Demystifying India -Understanding common myths and truths surrounding one of the fastest growing clinical trial markets" published July 31, 2009, author: Dan McDonald - VP, Business Strategy, Excel Life Sciences:

"But India can be as confusing and slow as much as it seems simple and efficient. It can be scary and overwhelming as much as it is warm and traditional. India can mean faster, lower-cost clinical trials, but it can also mean 85 people sitting in the waiting room of a small eye clinic at 9:00pm hoping to get a visit with a doctor before he leaves at 10:00pm after putting in a 14 hour day. Most will have to go home and try again tomorrow—even though home may be two hours away."

Click here to read the full article.